ABOS
Price
$1.04
Change
+$0.04 (+4.00%)
Updated
Jun 3 closing price
Capitalization
63M
75 days until earnings call
ATOS
Price
$0.85
Change
-$0.02 (-2.30%)
Updated
Jun 3 closing price
Capitalization
111.96M
75 days until earnings call
Interact to see
Advertisement

ABOS vs ATOS

Header iconABOS vs ATOS Comparison
Open Charts ABOS vs ATOSBanner chart's image
Acumen Pharmaceuticals
Price$1.04
Change+$0.04 (+4.00%)
Volume$336.23K
Capitalization63M
Atossa Therapeutics
Price$0.85
Change-$0.02 (-2.30%)
Volume$603.85K
Capitalization111.96M
ABOS vs ATOS Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. ATOS commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Buy and ATOS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ABOS: $1.04 vs. ATOS: $0.85)
Brand notoriety: ABOS and ATOS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 150% vs. ATOS: 82%
Market capitalization -- ABOS: $63M vs. ATOS: $111.96M
ABOS [@Biotechnology] is valued at $63M. ATOS’s [@Biotechnology] market capitalization is $111.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileATOS’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • ATOS’s FA Score: 1 green, 4 red.
According to our system of comparison, ATOS is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 1 TA indicator(s) are bullish while ATOS’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 1 bullish, 4 bearish.
  • ATOS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ATOS is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а +1.96% price change this week, while ATOS (@Biotechnology) price change was +1.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

ATOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATOS($112M) has a higher market cap than ABOS($63M). ATOS YTD gains are higher at: -9.734 vs. ABOS (-39.535). ATOS has higher annual earnings (EBITDA): -29.46M vs. ABOS (-77.89M). ABOS has more cash in the bank: 200M vs. ATOS (74.8M). ATOS has less debt than ABOS: ATOS (0) vs ABOS (28.5M). ABOS (0) and ATOS (0) have equivalent revenues.
ABOSATOSABOS / ATOS
Capitalization63M112M56%
EBITDA-77.89M-29.46M264%
Gain YTD-39.535-9.734406%
P/E RatioN/AN/A-
Revenue00-
Total Cash200M74.8M267%
Total Debt28.5M0-
FUNDAMENTALS RATINGS
ATOS: Fundamental Ratings
ATOS
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSATOS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
77%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHAT1.720.06
+3.61%
Blue Hat Interactive Entertainment Technology
MPX8.220.18
+2.24%
Marine Products Corp
ELV378.961.91
+0.51%
Elevance Health
SPHR37.940.08
+0.21%
Sphere Entertainment Co
COLD16.470.01
+0.06%
Americold Realty Trust

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+4.00%
FHTX - ABOS
50%
Loosely correlated
+4.56%
BEAM - ABOS
49%
Loosely correlated
+4.26%
ALEC - ABOS
49%
Loosely correlated
+7.25%
ATOS - ABOS
49%
Loosely correlated
-1.68%
ABCL - ABOS
49%
Loosely correlated
+7.94%
More

ATOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATOS has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATOS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATOS
1D Price
Change %
ATOS100%
-1.68%
ABOS - ATOS
48%
Loosely correlated
+4.00%
ABCL - ATOS
46%
Loosely correlated
+7.94%
NKTR - ATOS
45%
Loosely correlated
-5.89%
PDSB - ATOS
44%
Loosely correlated
+8.51%
ERAS - ATOS
44%
Loosely correlated
+1.40%
More